Does transcatheter aortic valve implantation improve clinical outcomes and LVEF in patients with severe left ventricular dysfunction?
TAVI appears safe and effective in critically ill patients with severe left ventricular dysfunction, offering early LVEF improvement.
Transcatheter aortic valve implantation is a safe and effective procedure, even in patients with severe left ventricular dysfunction, leading to a high procedural success rate with an acceptable rate of complications and 30-day mortality. Also in these critically ill patients, TAVI provides clinical amelioration, with early improvement in LVEF.
Fraccaro et al. (2012) studied this question.